AgeX Therapeutics Reports Second Quarter 2022 Financial Results

12.08.2022 - AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for the quarter ended June 30, 2022. Liquidity and Capital Resources ...

Related Keywords

United States ,American , ,Paycheck Protection Program Loan ,Linkedin ,Twitter ,Lifemap Sciences Inc ,Chardan Capital ,Juvenescence Limited ,Agex Therapeutics Inc ,Youtube ,Lifemap Sciences ,Facebook ,Convertible Facility Agreement ,Secured Convertible Promissory Note ,Secured Note ,Sales Agreement ,Accounting Standards Update ,Financial Statements Going Concern ,Quarterly Report ,Tissue Regeneration ,Private Securities Litigation Reform Act ,Agex Therapeutics ,Annual Report ,Exchange Commissions ,Agex Therapeutics Stock ,